Anti-Cancer Agents in Medicinal Chemistry

(Formerly Current Medicinal Chemistry - Anti-Cancer Agents)


Simone Carradori
Department of Pharmacy
“G. d’Annunzio” University of Chieti-Pescara

Personal Subscription
Become EABM
Become Reviewer

Editorial [Hot Topic:Preamble: CDC25 Phosphatases in Cancer and CDC25 Inhibitors (Guest Editor: Gregoire Pierre Prevost)] promotion: free to download

Volume:8   Issue: 8
Pp: 817-817
Gregoire Pierre Prevost
DOI: 10.2174/187152008786847774

Cell Cycle Control by the CDC25 Phosphatases

Volume:8   Issue: 8
Pp: 818-824
Bernadette Aressy and Bernard Ducommun
DOI: 10.2174/187152008786847756

CDC25A: A Rebel Within the CDC25 Phosphatases Family?

Volume:8   Issue: 8
Pp: 825-831
Anne Fernandez-Vidal, Anne Mazars and Stephane Manenti
DOI: 10.2174/187152008786847684

Is Cdc25 a Druggable Target?

Volume:8   Issue: 8
Pp: 837-842
John S. Lazo and Peter Wipf
DOI: 10.2174/187152008786847738

Cdc25B Phosphatase Inhibitors in Cancer Therapy: Latest Developments, Trends and Medicinal Chemistry Perspective

Volume:8   Issue: 8
Pp: 843-856
Antonio Lavecchia, Antonio Coluccia, Carmen Di Giovanni and Ettore Novellino
DOI: 10.2174/187152008786847783

CDC25 Inhibitors as Anticancer Agents Are Moving Forward

Volume:8   Issue: 8
Pp: 857-862
M.-C. Brezak, P. G. Kasprzyk, M.-O. Galcera, O. Lavergne and G. P. Prevost
DOI: 10.2174/187152008786847701

Cdc25A Protein Phosphatase: A Therapeutic Target for Liver Cancer Therapies

Volume:8   Issue: 8
Pp: 863-871
Z. Wang, S. Kar and B. I. Carr
DOI: 10.2174/187152008786847675

Chemical and Clinical Development of Darinaparsin, a Novel Organic Arsenic Derivative

Volume:8   Issue: 8
Pp: 904-909
Alfonso Quintas-Cardama, Srdan Verstovsek, Emil Freireich, Hagop Kantarjian, Yi Wen Chen and Ralph Zingaro
DOI: 10.2174/187152008786847666

Autotaxin Inhibition: Challenges and Progress Toward Novel Anti-Cancer Agents

Volume:8   Issue: 8
Pp: 917-923
Abby L. Parrill and Daniel L. Baker
DOI: 10.2174/187152008786847765